Trial Outcomes & Findings for Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study) (NCT NCT03694171)

Results Overview

Treatment administration was defined as any cancer treatment (versus no treatment) including curative, palliative and symptomatic treatments. This information was registered by registries and qualified as unknown when no information was available about treatment receipt.

Recruitment status

COMPLETED

Target enrollment

450 participants

Primary outcome timeframe

At diagnosis

Results posted on

2025-10-03

Participant Flow

Participant milestones

Participant milestones
Measure	Older Patients With Cancer Subjects i) aged 65 years and over from the PAQUID, the 3City or the AMI study; ii) alive on January 1st 2005 (common start date of tumor recording); iii) resident in Gironde; and iv) with a validated cancer diagnosis recorded in one of the cancer registries from January 1st 2005 to December 31st 2014. We included all invasive malignant tumors (including skin tumors) and benign tumors of the central nervous system. For patients with multiple tumors, only one was considered: i) the first one diagnosed if there were several tumors with a minimum of a 6 months interval between their diagnosis, ii) the one with the worse prognosis if there were several tumors diagnosed within less than 6 months. Any cancer treatment
Overall Study STARTED	450
Overall Study COMPLETED	450
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Older Patients With Cancer n=450 Participants Subjects i) aged 65 years and over from the PAQUID, the 3City or the AMI study; ii) alive on January 1st 2005 (common start date of tumor recording); iii) resident in Gironde; and iv) with a validated cancer diagnosis recorded in one of the cancer registries from January 1st 2005 to December 31st 2014. We included all invasive malignant tumors (including skin tumors) and benign tumors of the central nervous system. For patients with multiple tumors, only one was considered: i) the first one diagnosed if there were several tumors with a minimum of a 6 months interval between their diagnosis, ii) the one with the worse prognosis if there were several tumors diagnosed within less than 6 months. Any cancer treatment
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	0 Participants n=5 Participants
Age, Categorical >=65 years	450 Participants n=5 Participants
Sex: Female, Male Female	204 Participants n=5 Participants
Sex: Female, Male Male	246 Participants n=5 Participants
Region of Enrollment France	450 participants n=5 Participants

PRIMARY outcome

Timeframe: At diagnosis

Treatment administration was defined as any cancer treatment (versus no treatment) including curative, palliative and symptomatic treatments. This information was registered by registries and qualified as unknown when no information was available about treatment receipt.

Outcome measures

Outcome measures
Measure	Older Patients With Cancer n=450 Participants Subjects i) aged 65 years and over from the PAQUID, the 3City or the AMI study; ii) alive on January 1st 2005 (common start date of tumor recording); iii) resident in Gironde; and iv) with a validated cancer diagnosis recorded in one of the cancer registries from January 1st 2005 to December 31st 2014. We included all invasive malignant tumors (including skin tumors) and benign tumors of the central nervous system. For patients with multiple tumors, only one was considered: i) the first one diagnosed if there were several tumors with a minimum of a 6 months interval between their diagnosis, ii) the one with the worse prognosis if there were several tumors diagnosed within less than 6 months. Any cancer treatment
Proportion of Patients Being Receiving Treatment Administration After Diagnosis	372 Participants

PRIMARY outcome

Timeframe: one year after diagnosis

The probability of being dead with or without receiving cancer treatment at least once (death)

Outcome measures

Outcome measures
Measure	Older Patients With Cancer n=450 Participants Subjects i) aged 65 years and over from the PAQUID, the 3City or the AMI study; ii) alive on January 1st 2005 (common start date of tumor recording); iii) resident in Gironde; and iv) with a validated cancer diagnosis recorded in one of the cancer registries from January 1st 2005 to December 31st 2014. We included all invasive malignant tumors (including skin tumors) and benign tumors of the central nervous system. For patients with multiple tumors, only one was considered: i) the first one diagnosed if there were several tumors with a minimum of a 6 months interval between their diagnosis, ii) the one with the worse prognosis if there were several tumors diagnosed within less than 6 months. Any cancer treatment
The Probability of Being Dead at One Year	35.5 percentage of participants

Adverse Events

Older Patients With Cancer

Serious events: 0 serious events

Other events: 0 other events

Deaths: 160 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Simone Mathoulin-Pélissier

Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR

Phone: +33 5 56 33 33 33

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place